Literature DB >> 30566713

Fibrin Glue and Internal Limiting Membrane Abrasion for Optic Disc Pit Maculopathy.

David R P Almeida, Eric K Chin, Parnian Arjmand, Gabriel Velez, Lucy P Evans, Vinit B Mahajan.   

Abstract

BACKGROUND AND
OBJECTIVE: To describe a novel surgical technique using pars plana vitrectomy (PPV), internal limiting membrane (ILM) abrasion, and intravitreal fibrin glue for the treatment of optic disc pit maculopathy. PATIENTS AND METHODS: Surgical case series technique with scanning electron microscopy (SEM) of human post-mortem eyes.
RESULTS: Using SEM, the authors demonstrate the persistent adherence of vitreous fragments to the optic disc following induction of posterior vitreous detachment in human postmortem eyes. The authors describe a surgical technique using PPV, Tano Diamond Dusted Membrane Scraper for an ILM abrasion, intravitreal fibrin glue (Tisseel), and gas-air exchange to seal optic disc pits. The authors report successful long-term visual and anatomical outcomes in three patients.
CONCLUSIONS: Intravitreal fibrin glue, when combined with ILM abrasion, may be a viable treatment option for optic disc pit maculopathy with good short- and long-term visual acuity outcomes. SEM shows that ILM abrasion removes vitreous fragments, which are persistently adherent and may lead to failure with other interventional techniques. [Ophthalmic Surg Lasers Imaging Retina. 2018;49:e271-e277.]. Copyright 2018, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30566713     DOI: 10.3928/23258160-20181203-18

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN: 2325-8160            Impact factor:   1.300


  2 in total

1.  Surgical Options for Optic Disc Pit Maculopathy: Perspectives and Controversies.

Authors:  Salvador Pastor-Idoate; Claudia García-Arumí Fusté; Luis García-Onrubia; Sergio Copete; José García-Arumí
Journal:  Clin Ophthalmol       Date:  2020-06-16

2.  Optic nerve pit maculopathy worsened during pregnancy: a case report.

Authors:  Laura A Torrado-Cobian; George D Fivgas
Journal:  BMC Ophthalmol       Date:  2021-01-07       Impact factor: 2.209

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.